NASDAQ: HTFL · Industrial Applications and Services · 8 alerts · CIK 1464521
Share price
$46.86Close, Nov 16
Market cap
$4.12B
Shares outstanding
87.89MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Heartflow, Inc. filings on SEC EDGAR ↗
Heartflow, Inc. reported a total asset base of $355.3 million as of September 30, 2026, with a significant accumulated deficit of $1.14 billion. The company remains focused on its Heartflow FFRCT and Plaque Analysis products while maintaining a liquid position of approximately $167.7 million in cash and short-term investments.
Heartflow reported Q3 2026 revenue of $72.9 million, a 57% year-over-year increase driven by strong U.S. case volume for its FFRCT and Plaque Analysis products. The company significantly raised its full-year 2026 revenue guidance to a range of $262 million to $264 million, citing rapid CCTA market growth and improved production efficiency.
Term
Q3 2026
“Our third quarter was excellent, with revenue accelerating for the third consecutive quarter and U.S. revenue growing at its fastest pace in 11 quarters. Our core FFRCT business remains durable, our installed base continues to expand rapidly, and activations of Heartflow Plaque Analysis are ramping ahead of plan, with utilization broadening across a wider share of applicable CCTAs.”
John Farquhar, President and CEO of Heartflow
“Strong performance across our diagnostic platform, along with disciplined execution of our commercial, innovation and clinical initiatives, gives us the confidence to raise our 2026 guidance once again. With continued momentum and a scaling business, we believe we are well-positioned to extend our market leadership, and we have increased confidence in our path to profitability.”
Heartflow CEO John C.m. Farquhar Sells $2.17M of Stock
John C.m. Farquhar, CEO, sold 38,900 shares of Heartflow, Inc. at $55.74 a share, worth $2.17M in total on Nov 10, 2026. Shares held after the trade: 251,983 (-13.4%).
Heartflow CFO Vikram Verghese Sells $191K of Stock
Vikram Verghese, CFO, sold 3,587 shares of Heartflow, Inc. at $53.15 a share, worth $191K in total on Nov 9, 2026. Shares held after the trade: 149,587 (-2.3%).
Heartflow CMO Campbell Rogers Sells $1.32M of Stock
Campbell Rogers, CMO, sold 23,933 shares of Heartflow, Inc. at $55.01 a share, worth $1.32M in total on Oct 22, 2026. Shares held after the trade: 73,453 (-24.6%).